The Imaging Core will provide essential support for the PET studies (Projects 1-3) and the MR studies (Project 2) proposed in this application. In these studies, multiple radiotracers will be administered intravenously to all research participants in conjunction with PET imaging. In Project 1, Parkinson's disease (PD) patients and healthy volunteer subjects will be scanned with [ [18] F]-FDG PET (to measure glucose metabolism), [[15] 0]-H20 PET (to visualize cerebral blood flow) and [ [82]Rb] PET (to assess blood brain barrier (BBB) permeability). In Project 2, PD patients will be scanned with [18] F-FDG (for glucose metabolism), [[11] C]-PIB (to detect protein aggregation), and [[18] F]-FPCIT (to trace striatal dopamine transporter binding). In Project 3, subjects will also undergo FPCIT PET imaging. The PET studies will be supported by the cyclotron/PET group within the Imaging Core. The planned fMRI studies in Project 2 will be supported by the MR group within the Imaging Core. The cyclotron/PET unit at the Feinstein Institute (FIMR) has been performing multi-tracer PET studies in patients with PD and other neurodegenerative diseases for over 20 years. The PET imaging lab and the cyclotron unit are located adjacent to each other in the basement ofthe FIMR. Resources are in place for the routine production and utilization of [18] F]-FDG, [[18] Oj-H2O, [ [11] C]-PIB, and [[18] F]-FPC1T for research studies. (The [[82] Rb] PET studies will utilize a commercially available generator as described below). The high-field MRI unit is located in the Department of Radiology of North Shore University Hospital, approximately 200 ft. from The Feinstein Institute building. The MR investigators within the Imaging Core share office and laboratory space with the other imaging investigators and often work together on disease-related projects that involve multiple imaging modalities. These investigators will optimize the MR image acquisition protocols proposed for Project 2 and will collect and process the relevant MR imaging data.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS071675-05
Application #
8742004
Study Section
Special Emphasis Panel (ZNS1-SRB-E)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
5
Fiscal Year
2014
Total Cost
$137,411
Indirect Cost
$54,633
Name
Feinstein Institute for Medical Research
Department
Type
DUNS #
110565913
City
Manhasset
State
NY
Country
United States
Zip Code
11030
Ko, Ji Hyun; Spetsieris, Phoebe G; Eidelberg, David (2018) Network Structure and Function in Parkinson's Disease. Cereb Cortex 28:4121-4135
Nazem, Amir; Tang, Chris C; Spetsieris, Phoebe et al. (2018) A multivariate metabolic imaging marker for behavioral variant frontotemporal dementia. Alzheimers Dement (Amst) 10:583-594
Ge, Jingjie; Wu, Jianjun; Peng, Shichun et al. (2018) Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts. Hum Brain Mapp 39:2842-2858
Argyelan, Miklos; Herzallah, Mohammad; Sako, Wataru et al. (2018) Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study. Neuroreport 29:532-540
Lerner, Renata P; Francardo, Veronica; Fujita, Koji et al. (2017) Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia. Sci Rep 7:16005
Hendershott, Taylor R; Zhu, Delphine; Llanes, Seoni et al. (2017) Domain-specific accuracy of the Montreal Cognitive Assessment subsections in Parkinson's disease. Parkinsonism Relat Disord 38:31-34
Jourdain, Vincent A; Schindlbeck, Katharina A; Tang, Chris C et al. (2017) Increased putamen hypercapnic vasoreactivity in levodopa-induced dyskinesia. JCI Insight 2:
Tomše, Petra; Jensterle, Luka; Rep, Sebastijan et al. (2017) The effect of 18F-FDG-PET image reconstruction algorithms on the expression of characteristic metabolic brain network in Parkinson's disease. Phys Med 41:129-135
Ng, Bernard; Varoquaux, Gael; Poline, Jean Baptiste et al. (2017) Distinct alterations in Parkinson's medication-state and disease-state connectivity. Neuroimage Clin 16:575-585
Vo, An; Sako, Wataru; Fujita, Koji et al. (2017) Parkinson's disease-related network topographies characterized with resting state functional MRI. Hum Brain Mapp 38:617-630

Showing the most recent 10 out of 47 publications